Bischloroanthrabenzoxocinone
Product Specifications
UNSPSC Description
Bischloroanthrabenzoxocinone is a potent Type II fatty acid synthesis (FASII) inhibitor. Bischloroanthrabenzoxocinone inhibits fatty acid synthesis. Bischloroanthrabenzoxocinone shows antibacterial activities and inhibits phospholipid, DNA, RNA, protein, and cell wall synthesis[1].
Target Antigen
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bischloroanthrabenzoxocinone.html
Solubility
10 mM in DMSO
Smiles
OC1=C(C(C2)=CC(C(C)(C3=C4Cl)C)=C1C(C3=C(C(Cl)=C4O)O)=O)[C@](O[C@@]25C)([H])C(C(O5)=CC(OC)=C6)=C6C
Molecular Weight
543.39
References & Citations
[1]Kodali S, et al. Determination of selectivity and efficacy of fatty acid synthesis inhibitors. J Biol Chem. 2005 Jan 14;280(2):1669-77.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135130/Bischloroanthrabenzoxocinone-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135130/
Clinical Information
No Development Reported
CAS Number
866022-28-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
